Today: 6 June 2026
Browse Category

NASDAQ:TOVX 16 October 2025 - 24 October 2025

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next?

Theriva shares surged 92% intraday Oct. 15 after its VCN-01 therapy met primary endpoints in a Phase 2b pancreatic cancer trial, then fell back following a $4 million equity raise. Median survival in a two-dose subgroup reached 14.8 months versus 11.6 for chemo alone. The company held $12.1 million cash as of June 30, 2025, funding operations into early 2026. Expanded trial results will be presented at ESMO Oct. 20.
24 October 2025
·

Stock Market Today

  • S&P Dow Jones Indices Maintains Current Eligibility Criteria for S&P 500 Inclusion
    June 6, 2026, 4:57 AM EDT. S&P Dow Jones Indices announced it will keep its current rules for adding companies to the S&P 500, MidCap 400, and SmallCap 600 indexes, including U.S. headquarters, listing requirements, and a 12-month trading minimum after an initial public offering (IPO). The decision follows feedback from market participants and contrasts with Nasdaq's recent move to expedite including large IPO companies in its Nasdaq 100 index. S&P stated that maintaining these criteria offers balanced market coverage and sector representation. The decision comes amid anticipation of major IPOs from AI and tech firms like SpaceX, Anthropic, and OpenAI, highlighting the significance of index inclusion for institutional investors such as pension funds and mutual funds.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 06.06.2026

6 June 2026
LIVEMarkets rolling coverageStarted: June 6, 2026, 4:00 AM EDTUpdated: June 6, 2026, 4:58 AM EDT S&P Dow Jones Indices Maintains Current Eligibility Criteria for S&P 500 Inclusion June 6, 2026, 4:57 AM EDT. S&P Dow Jones Indices announced it will keep its current rules for adding companies to the S&P 500, MidCap 400, and SmallCap 600 indexes, including U.S. headquarters, listing requirements, and a 12-month trading minimum after an initial public offering (IPO). The decision follows feedback from market participants and contrasts with Nasdaq’s recent move to expedite including large IPO companies in its Nasdaq 100 index. S&P stated that
Rigetti Stock Drops After Quantum Surge Stalls on Wall Street Rate Jolt

Rigetti Stock Drops After Quantum Surge Stalls on Wall Street Rate Jolt

6 June 2026
Rigetti Computing plunged 14.5% to $20.68 as tech stocks tumbled after strong May payrolls fueled fears of prolonged high U.S. rates, pressuring long-duration names; the selloff highlights risks tied to government funding, potential equity dilution, and uncertain commercial milestones, with Rigetti posting a $26 million Q1 operating loss and $4.4 million revenue despite recent product and funding announcements.
POET Technologies Stock Drops Sharply as Investors Watch

POET Technologies Stock Drops Sharply as Investors Watch

6 June 2026
POET Technologies plunged 23% to $11.86 amid a semiconductor selloff, as investors weighed execution risks after a $400 million capital raise, a $50 million Lumilens order, and recent turbulence from Marvell’s canceled purchase orders, with dilution and tax-status questions adding pressure.
Flex grabs S&P 500 spot but shares drop

Flex grabs S&P 500 spot but shares drop

6 June 2026
Flex will join the S&P 500 on June 22, drawing investor focus to its surging AI data-center power unit and planned spin-off, even as shares fell 4.8% to $151.92 amid a tech selloff; CPI sales jumped 38% to $6.61 billion in fiscal 2026, now 24% of total revenue, but margin slipped 100 basis points due to ramp-up costs and product mix.
Intel shares hit as AI chip slump wipes out $1.3 trillion

Intel shares hit as AI chip slump wipes out $1.3 trillion

6 June 2026
Intel plunged 11.4% to $99.17 on heavy volume as the PHLX Semiconductor Index suffered its worst drop since March 2020, wiping out $1.3 trillion in U.S. chipmaker market value, overshadowing Intel’s new AI partnership with Foxconn amid sector-wide selling triggered by Broadcom’s guidance and renewed Fed rate hike fears.
Go toTop